Corcept Therapeutics Overview
Corcept Therapeutics Target Price
Analysts' 12-month price predictions for CORT.
Share Price
$69.37
Average Target Price
$140.00
101.8% upside
101.8% upside2 analysts in the last 4 months
High: $145 | Low: $135
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-06 | Truist FinancialJoon Lee | $135 | 94.6% upside |  |
| 2025-05-06 | H.C. WainwrightSwayampakula Ramakanth | $145 | 109% upside | |
| 2024-10-18 | H.C. WainwrightSwayampakula Ramakanth | $80 | 15.3% upside | |
| 2024-09-30 | Truist FinancialJoon Lee | $76 | 9.6% upside | |
| 2024-08-15 | Canaccord GenuityEdward Nash | $78 | 12.4% upside | |
| 2024-07-30 | Piper SandlerDavid Amsellem | $38 |  45.2% downside | |
| 2024-07-30 | H.C. WainwrightSwayampakula Ramakanth | $45 | 35.1% downside | |
| 2024-06-12 | Canaccord GenuityEdward Nash | $38 | 45.2% downside | |
| 2024-06-10 | Piper SandlerDavid Amsellem | $35 | 49.5% downside | |
| 2024-06-04 | Truist FinancialJoon Lee | $65 | 6.3% downside | |
| 2024-05-02 | H.C. WainwrightSwayampakula Ramakanth | $40 | 42.3% downside | |
| 2022-12-09 | H.C. Wainwright | $30 | 56.8% downside | |
| 2022-08-04 | H.C. Wainwright | $33 | 52.4% downside | |